MeSH tree: C10.228.854.139
New research reveals a type of monoclonal antibody already tested in certain forms of cancer may be a promising treatment in stopping the progression of amyotrophic lateral sclerosis, or ALS, a fatal neurodegenerative disease.
Jul 31, 2023
0
78
Recent neuroscience studies have consistently outlined the role of the C9ORF72 gene in the development of some neurodegenerative diseases. These studies found that mutations of this gene increase the risk of developing amyotrophic ...
Researchers at the Francis Crick Institute and UCL have shown that hundreds of proteins and mRNA molecules are found in the wrong place in nerve cells affected by motor neuron disease (MND), also known as amyotrophic lateral ...
Jul 21, 2023
0
679
New research suggests that targeting autoimmune inflammation associated with amyotrophic lateral sclerosis (ALS) using two drugs, one of them already approved for multiple sclerosis, could be a promising approach for treatment.
Jul 13, 2023
0
32
The European Union drug watchdog's refusal to approve an ALS drug already authorized in North America has been called "an affront" by angry French patients, who say they "don't have time to wait".
Jun 29, 2023
0
36
Several people with autism and intellectual disabilities have been legally euthanized in the Netherlands in recent years because they said they could not lead normal lives, researchers have found.
Jun 28, 2023
0
41
Consuming omega-3 fatty acids—particularly alpha-linolenic acid (ALA), a nutrient found in foods including flaxseeds, walnuts, and chia, canola and soybean oils—may help slow the progression of disease in patients with amyotrophic ...
Jun 21, 2023
0
331
Among the tens of thousands of Americans with amyotrophic lateral sclerosis, or ALS, most do not have a single genetic mutation shown to cause the fatal disease.
Jun 21, 2023
0
44
A unique type of muscle fiber found in the extraocular muscles has been shown to be resistant against the disease amyotrophic lateral sclerosis (ALS), and has been shown to even increase in proportion to compensate when other ...
Jun 19, 2023
0
53
The Department of Neurology at Niigata University has developed a new in silico method for evaluating the pathogenicity of missense variants using AlphaFold2 (MOVA).
Jun 14, 2023
0
34
